Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.36 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
| ▸ | GABRP | O00591 | 2/20 | 0.30 |
| ▸ | GABRD | O14764 | 2/20 | 0.30 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.30 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.30 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.30 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.30 |
| ▸ | GABRE | P78334 | 2/20 | 0.30 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL319288 | 0.87 | — | — | |
| SCHEMBL179976 | 0.87 | — | — | |
| Butadiene SCHEMBL1172510 | 0.80 | TSHR (0.40) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Fumaric Acid SCHEMBL28230141 | 0.76 | TSHR (0.64) | TSHRTP53EGLN1EGLN3SMN1; SMN2 | |
| Maleic Acid SCHEMBL7183468 | 0.76 | TSHR (0.64) | TSHRTP53EGLN1EGLN3SMN1; SMN2 | |
| Fumaric Acid SCHEMBL7183473 | 0.76 | TSHR (0.64) | TSHRTP53EGLN1EGLN3SMN1; SMN2 | |
| Glycine SCHEMBL5168496 | 0.74 | GLRA1 (0.46) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Methacrylic Acid SCHEMBL5169381 | 0.74 | TSHR (0.35) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Maleic Acid SCHEMBL28102294 | 0.73 | TSHR (0.60) | TSHRTP53EGLN1EGLN3SMN1; SMN2 | |
| SCHEMBL6469047 | 0.73 | TSHR (0.33) | TSHRTP53EGLN1EGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160161475-A1 | HYBRID SEMICONDUCTING POLYMER NANOPARTICLES AS POLARIZATION-SENSITIVE FLUORESCENT PROBES | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION | 2016-06-09 | — | — | US | claimed |
| EP-3019443-A1 | HYBRID SEMICONDUCTING POLYMER NANOPARTICLES AS POLARIZATION SENSITIVE FLUORESCENT PROBES | University Of Washington Through Its Center For Commercialization (US) | 2016-05-18 | — | — | EP | claimed |
| US-20160018405-A1 | METHODS AND SYSTEMS FOR ANALYSIS USING POLYMER DOTS | University of Washington Through it's Center for Commercialization (US) | 2016-01-21 | — | — | US | claimed |
| EP-2653867-A1 | Biotracer and its use in an immunoassay | King Saud University (SA) | 2013-10-23 | — | — | EP | claimed |
| EP-3277846-B1 | OPTICAL PAINTING AND FLUORESCENCE-ACTIVATED SORTING OF ADHERENT CELLS | UNIV WASHINGTON (US) | 2024-07-10 | — | — | EP | disclosed |
| US-20240069032-A1 | FUNCTIONALIZED CHROMOPHORIC POLYMER DOTS AND BIOCONJUGATES THEREOF | CLEMSON UNIVERSITY RESEARCH FOUNDATION | 2024-02-29 | — | — | US | disclosed |
| US-20230408526-A1 | CHROMOPHORIC POLYMER DOTS | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2023-12-21 | — | — | US | disclosed |
| US-11835526-B2 | Functionalized chromophoric polymer dots and bioconjugates thereof | UNIVERSITY OF WASHINGTON (US) | 2023-12-05 | — | — | US | disclosed |
| US-11753681-B2 | Digital nucleic acid amplification using encoded particles | UNIVERSITY OF WASHINGTON (US) | 2023-09-12 | — | — | US | disclosed |
| US-11674964-B2 | Encoded chromophoric polymer particles and methods of use thereof | UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) | 2023-06-13 | — | — | US | disclosed |
| US-20230159979-A1 | TRANSDUCERS, NANOPARTICLE TRANSDUCER DEVICES AND SYSTEMS, AND RELATED METHODS OF USE | UNIVERSITY OF WASHINGTON (US) | 2023-05-25 | — | — | US | disclosed |
| US-20230077385-A1 | NANOPARTICLE TRANSDUCER SENSORS AND METHODS OF USE THEREOF | UNIVERSITY OF WASHINGTON (US) | 2023-03-16 | — | — | US | disclosed |
| WO-2012054525-A2 | CHROMOPHORIC POLYMER DOTS | University of Washington Center for Commercialization (US) | 2012-04-26 | — | — | WO | disclosed |
| WO-2011057295-A2 | FUNCTIONALIZED CHROMOPHORIC POLYMER DOTS AND BIOCONJUGATES THEREOF | University of Washington Center for Commercialization (US) | 2011-05-12 | — | — | WO | disclosed |
| US-7846412-B2 | Nanoparticle fluorescent probes comprised of quantum dot and hydrophobic protection structure including capping ligand and amphiphilic copolymer; biocompatibility; multiplexed imaging and detection of genes and proteins in single living cells; cancer diagnosis | EMORY UNIVERSITY (US) | 2010-12-07 | — | — | US | disclosed |
| WO-2008137733-A2 | MICELLAR STRUCTURES, METHODS OF MAKING MICELLAR STRUCTURES, METHODS OF IMAGING, AND METHODS OF DELIVERING AGENTS | EMORY UNIVERSITY (US) | 2008-11-13 | — | — | WO | disclosed |
| WO-2008116044-A1 | SEMICONDUCTOR QUANTUM DOTS FOR EFEICIENT DELIVERY AND INTRACELLULAR IMAGING OF SIRNA | EMORY UNIVERSITY (US) | 2008-09-25 | — | — | WO | disclosed |
| EP-1696784-A2 | BIOCONJUGATED NANOSTRUCTURES, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | Emory University (US) | 2006-09-06 | — | — | EP | disclosed |
| WO-2005065081-A2 | BIOCONJUGATED NANOSTRUCTURES, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF | EMORY UNIVERSITY (US) | 2005-07-21 | — | — | WO | disclosed |
| US-20050136258-A1 | Nanoparticle fluorescent probes comprised of quantum dot and hydrophobic protection structure including capping ligand and amphiphilic copolymer; biocompatibility; multiplexed imaging and detection of genes and proteins in single living cells; cancer diagnosis | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-06-23 | — | — | US | disclosed |